Given the recent shift from the one-size-fits-all model to a more personalized mode of treatment, there has been a growing interest in identification and adoption of novel techniques. It is estimated that there are around 20,000 genes present in the human body, all of which interact with the nutrients in the food, either directly or indirectly. Since the introduction of a gene sequencing method by Frederick Sanger in 1977, the field of genomic data collection and analysis has evolved significantly.

Advances in DNA sequencing technologies have enabled significant developments in a variety of healthcare-focused research fields, such as precision medicine and diagnostics. Further, the success of the Human Genome Project, which mapped the whole human DNA, has paved a path for the novel concept of nutrigenomics, the science studying the relationship between human genome, nutrition and health.

Presently, extensive studies are being conducted to understand the interaction between nutrients and gene expression at the molecular level to determine effect of a specific nutrient and dietary regime on the human health. Although the field of nutritional genomics is still in a nascent stage, it is a moving at a very fast-pace and is believed to have the potential to lay the foundation for personalized nutrition offerings. Further, the growing interest in nutrigenomics is supported by the rising awareness about the influence of diet on human health and its potential with respect to minimizing the risk of various diet-related diseases, including diabetes, cardiovascular disorders, chronic respiratory diseases and oncological disorders.

Type of Sample

Saliva

Other Samples

Type of Sample Collection Methods

At-Home Sample Collection

Lab Sample Collection

Key Geographical Regions

North America

Europe

Asia-Pacific

Latin America

Middle East and North Africa

Rest of the World

Key Companies Nutrigenomics Market Profiled

3X4 Genetics

Advanced Nutrigenomics

DNAlysis Biotechnology

DNA Health and Wellness

Geno Palate

Mapmygenome

Nutrigenetics

Vieroots

Vitagenum

This field is evolving continuously, as researchers and industry players alike aim to enhance the existing offerings. In this context, in the past 3 years, over 135 nutrigenomics focused research articles have been published, highlighting the active initiatives of researchers to illustrate the effect of nutrition on regulation of gene expression. At present, there are some ethical and regulatory challenges associated with nutrigenomics, including the potential misuse of personal data, as well as uncertainty related to genetic phenotypic predispositions, for conditions where no proven treatment exists. However, the benefits offered by nutrigenomics outweigh the uncertainty associated with its adoption. Considering the growing focus on personalized diets and active initiatives being undertaken by players in this domain, we are led to believe that the opportunity for stakeholders in this niche, but upcoming, industry is likely to grow at a commendable pace in the foreseen future.?

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/nutrigenomics-market.html

About Roots Analysis

Roots Analysisis a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:

Roots Analysis

Sales@rootsanalysis.com

However, Owing to the complexities involved in the development of small molecule drugs and lack of sufficient in-house capacity, drug developers prefer to outsource their fill finish operations. Therefore, the pharmaceutical fill finish CMOs are anticipated to contribute significantly in the healthcare domain in the coming years.

Examples of key companies engaged in fill finish pharmaceutical contract manufacturing market (which have also been profiled in this market report; the complete list of companies is available in the full report) include (in alphabetic order) Alcami, Amanta Healthcare, Aurigene Services, Batterjee Pharma, Burrard Pharmaceuticals, Curida, Eriochem, Fresenius Kabi, GlaxoSmithKline, Nextar Chempharma Solutons, Pfizer CentreOne, Plastikon Healthcare, Procaps, Recipharm, ROMMELAG CMO, Sharp Services, Sypharma, Teva Pharmaceuticals and WuXi AppTec.

Fill Finish Pharmaceutical Contract Manufacturing Market Segments

Based on the type of fill finish service offered, the market is segmented into aseptic filling, blow-fill-seal and terminal sterilization.

The terminal sterilization segment is likely to capture the largest revenue share of close to 45% in the fill finish pharmaceutical contract manufacturing market, in 2024.

The aseptic filling segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 5.4% during the forecast period.

Based on the type of FDF, the market is segmented into generic FDF and originator FDF.

The originator FDF segment is likely to capture the largest revenue share of close to 55% in the fill finish pharmaceutical contract manufacturing market, in 2024.

The generic segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 5.4% during the forecast period.

Based on the type of API potency, the market is segmented into low potent API and high potent API.

The low potent API segment is likely to capture the largest revenue share of more than 85% in fill finish pharmaceutical contract manufacturing market, in 2024.

The high potent API segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 9% during the forecast period.

Based on the type of primary packaging container, the market is segmented into ampoules, cartridges, prefilled syringe, vials and other containers.

The vials segment is likely to capture the largest revenue share of 50% in the fill finish pharmaceutical contract manufacturing market, in 2024.

The other containers segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 7.5% during the forecast period.

Based on the scale of operation, the market is segmented into clinical and commercial scale.

The commercial segment is likely to capture the largest revenue share of 95% in the fill finish pharmaceutical contract manufacturing market, in 2024.

The clinical segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 7.4% during the forecast period.

Based on the company size, the market is segmented into small and mid-sized companies and large / very large companies.

The large / very large companies segment is likely to capture the largest revenue share of 90% in the fill finish pharmaceutical contract manufacturing market, in 2024.

The small and mid-sized companies segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 6.9% during the forecast period.

Based on the Regional Insights, the market is segmented North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa

Europe dominated the fill finish pharmaceutical contract manufacturing market and is likely to account for the largest revenue share of close to 40% in 2024.

In rest of the world, fill finish pharmaceutical contract manufacturing market is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 11% during the forecast period.

Fill Finish Pharmaceutical Contract Manufacturing Market Regional Outlook

Based on the geographical regions, the fill finish pharmaceutical contract manufacturing market can be segmented into five major regions, including North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and rest of the world. Europe is anticipated to capture the majority share of the fill finish pharmaceutical contract manufacturing market in 2024. Further, the fill finish pharmaceutical contract manufacturing industry in rest of the world is accounted to be the fastest-growing segment of the market. This is primarily due to the rising demand for small molecule drugs targeting various diseases.?

Key Report Takeaways

Currently, close to 390 CMOs offering fill finish manufacturing services for small molecules are available across the world; majority of the solution providers are based in North America and Europe

Owing to the financial prosperity and the cultural norms present in the region, the US has emerged as a hub of the established players and the new entrants in this industry

Owing to rising need for small molecule drug products, the fill finish pharmaceutical contract manufacturing market is anticipated to witness an annualized growth of 4.8%, over the next decade

About Roots Analysis

Roots Analysis is a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary

Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com